Menu

Vincent MONTAUBAN

PARIS

En résumé

My career

I'm General Practitioner. I started my career in R&D, in Janssen-Cilag and Takeda. Then I joined Astellas (former Yamanouchi), with whom I held various positions, always in the medical affairs for 7 years in Urology and Gynecology. In 2008, I took the Medical Direction of Shire HGT France, company specialized in genetic and rare diseases. Then, I moved in 2014 to Baxter Bioscience Division.

Why?

For challenges, to discover a new world, to renew me, scientifically like that of the relational network, while the company benefit from my experience in the previous field.

What interests me in my profession?

My job brings me to learn every day, whether documenting me in the scientific literature, attending conferences or in my contacts with the medical profession, especially opinion leaders. Information flows in both directions. We are talking between doctors on the subject of medical progress, which change quickly particularly in this area. These exchanges are much richer especially as Baxter is a very promising laboratory with very rich pipeline in hemophilia, onco-hematology and immunology. I must be at the forefront in many specialties.


JOB DESCRIPTION

* Established KOL relationships; strategy for France ;
* Lead Advisory Board strategy, relationships with the KOL and patient organization, animation of groups of experts
* Developed and Lead `Medical Affairs strategy' for newly licensed and existing products
* Permanent and close cooperation with the Marketing Products Managers and regulatory affairs; promotional and scientific materials approval
* Organization of symposia, scientific events, external meetings
* Participation in French and international congresses ;
* Elaboration and contribution in epidemiological investigations and registers ;
* Medical writing ;
* Team trainings of Sale forces; Participation in sale reps' seminars ;
* Provide Medical Information ;
* Support to Clinical Operations (phase II to IV, post marketing)
* Support Market Access and meetings with Health Authorities
* Experience in Orphan drug, rare disease area
* People Management and Leadership ;

Mes compétences :
Urology
Oncology
Immunology
Haemophilia
Gynaecology and Obstetrics
Pharmacovigilance
People Management
Management of two CRA and one assistant
Dermatology
Clinical development support
Clinical Operations

Entreprises

  • BAXALTA (former BAXTER HEALTHCARE) - Medical Director Immunology

    2014 - maintenant BAXALTA (FORMER BAXTER HEALTHCARE FRANCE- BIOSCIENCE BUSINESS UNIT)
    Medical Director Bioscience BU France / Immunology BU

    Management of 5 people (2 MSLs, 1 project manager, 1 scientific and communication manager, 1 admin)
    Areas covered: Immunology and Hemophilia
  • Shire - Medical Director

    Boulogne-Billancourt 2008 - 2014 Management of two MSLs
    Two launches in 2009 Firazyr (hereditary angioedema) and in 2010 VPRIV (Gaucher disease)
    Four products (Replagal®, Elaprase®, Firazyr®, VPRIV®)
    Key achievements:
    Actively contribute to post-marketing studies committed to HAS. The particularity of researches in rare diseases (low number of patients) forces the Shire to maintain through registries (database) the capture of the efficacy and the safety of our products. The reorganisation permitted to recruit in France, half of the whole cohort in HAE because my ability to implement the best support to the centres.
    Reorganized the Medical department for optimal functioning to achieve targets and to support the business on a niche market. Staffed the department as per the need of the business. Assessed the divisional requirements and built a new team. Defined training requirements.
  • Astellas Pharma - Medical Affairs and Scientific Manager

    Levallois-Perret 2002 - 2008 Since the merger in 2005 (Yamanouchi/Fujisawa)
    Management of one assistant and one scientific information manager
    Two launches in 2006 (Eligard®: LHRH agonist and Omexel®: α-blocker)
    One Launch in 2008 (Eligard® 6 month formulation)
    Clinical development support in Oncology Survivin inhibitor/angiogenesis inhibitor

    Medical Director Urology ,
  • Takeda - Medical Project Manager / CLINICAL DEVELOPMENT

    Puteaux 1998 - 2002 Medical Project Manager
    Management of phase IIb and III studies (Leuprorelin: urology, gynecology and pediatry)
    Managing one secretary and 4 clinical research associates
    Writing reports for indication extension
  • Johnson & Johnson - Clinical trial Manager / CLINICAL DEVELOPMENT

    New Brunswick 1997 - 1998 Trial Center Manager
    Follow up of phase I to III studies (dermatology and infectiology)
  • Roche - Stagiaire / CLINICAL DEVELOPMENT

    Boulogne-Billancourt 1996 - 1997 6 months Training as Project Manager
  • Médecin Généraliste - Médecin Généraliste

    1994 - 1996

Formations

Réseau

Annuaire des membres :